Alantolactone curbs the malignant progression of bladder cancer partly via the HSP90AB1/LRP5/beta-catenin axis. Zhi L, Yuan L. Mamm Genome 2025;37:20.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhi L, Yuan L. Alantolactone curbs the malignant progression of bladder cancer partly via the HSP90AB1/LRP5/beta-catenin axis. Mamm Genome 2025;37:20.
PMID: 41436627